-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Xenon Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2021 to Q3 2024.
- Xenon Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $10.6M, a 49.6% increase year-over-year.
- Xenon Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $41.7M, a 40.4% increase year-over-year.
- Xenon Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was $31.4M, a 707% increase from 2022.
- Xenon Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2022 was $3.89M, a 3603% increase from 2021.
- Xenon Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2021 was $105K, a 95.2% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)